Health Ministry Finds Three TB Genome Variants in Study of 7,000 Patients
Badung, Bali (ANTARA) — Indonesia’s Ministry of Health has identified three tuberculosis (TB) genome variants through research involving 7,000 TB patients in various parts of the country.
Speaking at the 40th Stop TB Partnership Board Meeting 2026 in Sunset Road, Badung Regency, Bali, on Thursday, Health Minister Budi Gunadi Sadikin said the research was funded by the Global Fund and used genome sequencing technology from Illumina and Oxford Nanopore.
The completed study found three TB variants with distinct characteristics associated with the country’s western, central and eastern regions.
Budi said further research was needed to establish whether the differences in TB genome characteristics across regions affect the effectiveness of vaccines or treatments being developed.
The findings are expected to provide a basis for developing more effective TB vaccines and treatments.
He said the research was important because the government wanted to ensure that the development of vaccine and medicine technologies took account of the characteristics of variants found in Indonesia.
The findings also form part of Indonesia’s efforts to strengthen health technology research and development to tackle TB.
Budi expressed his appreciation to the Global Fund for supporting the genome sequencing research involving 7,000 TB patients.
Indonesia is also taking part, alongside several other countries, in a phase-three clinical trial of the M72 TB vaccine. The government is preparing clinical trials of a new TB medicine that is expected to shorten the duration of treatment.
Budi hoped the genomic research would contribute to the development of new vaccines and treatments, enabling Indonesia to tackle TB more effectively.
“Nothing reaches patients by chance. We need to screen patients, provide treatment and deliver vaccines to them,” he said.
At the international forum, Budi also highlighted Indonesia’s high TB death toll of 136,000. This makes Indonesia the country with the world’s second-highest number of TB cases, after India.
He said the high death toll should spur the government to accelerate its efforts to combat TB.
According to Budi, on average two Indonesians die of TB for every five minutes he speaks at the forum.
He stressed that the response to TB must not spend too long in discussion and administrative processes.
The government needs to accelerate concrete action, including approvals from the National Agency of Drug and Food Control (BPOM), also known as the Indonesian FDA.
Budi warned that approval delays of up to a year could have a major impact on public safety.
With the death toll at 136,000, faster policy decisions and action are urgently needed.
He therefore asked his team to spend less time in discussion and focus more on implementing programmes and taking concrete steps to reduce TB deaths.
“It is better to speed up approvals and action,” Budi said.
Source: jawawa.id (https://jawawa.id/newsitem/health-ministry-finds-three-tb-genome-variants-in-study-of-7-000-patients-1793858093)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5833323/kemenkes-temukan-tiga-varian-genom-tbc-dari-penelitian-7000-pasien), translated from Indonesian